427 POSTER Pharmacokinetics (PK) of EZN-2208, a novel anticancer agent, in patients (pts) with advanced malignancies: a phase I dose-escalation study

2008 ◽  
Vol 6 (12) ◽  
pp. 134 ◽  
Author(s):  
A. Patnaik ◽  
M. Goldston ◽  
C. Takimoto ◽  
A. Tolcher ◽  
K. Papadopoulos ◽  
...  
Keyword(s):  
Phase I ◽  
Dose Escalation ◽  
Anticancer Agent ◽  
Dose Escalation Study ◽  
Advanced Malignancies

A phase I dose-escalation study of XL147 (SAR245408), a PI3K inhibitor administered orally to patients (pts) with advanced malignancies.

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. 3004-3004 ◽  
Author(s):  
G. Edelman ◽  
C. Bedell ◽  
G. Shapiro ◽  
S. S. Pandya ◽  
E. L. Kwak ◽  
...  
Keyword(s):  
Phase I ◽  
Dose Escalation ◽  
Pi3k Inhibitor ◽  
Dose Escalation Study ◽  
Advanced Malignancies

Phase I dose escalation study of pegylated liposomal doxorubicin (Caelyx®) in combination with topotecan in patients with advanced malignancies

2006 ◽  
Vol 24 (5) ◽  
pp. 413-421 ◽  
Author(s):  
Hervé Ghesquières ◽  
Sandrine Faivre ◽  
Latifa Djafari ◽  
Patricia Pautier ◽  
Catherine Lhommé ◽  
...  
Keyword(s):  
Phase I ◽  
Dose Escalation ◽  
Liposomal Doxorubicin ◽  
Pegylated Liposomal Doxorubicin ◽  
Dose Escalation Study ◽  
Advanced Malignancies

scholarly journals Phase I dose-escalation study of the thioxanthone SR271425 administered intravenously once every 3 weeks in patients with advanced malignancies

2008 ◽  
Vol 26 (4) ◽  
pp. 347-354 ◽  
Author(s):  
Priscila H. Goncalves ◽  
Francine High ◽  
Paul Juniewicz ◽  
Gareth Shackleton ◽  
Jing Li ◽  
...  
Keyword(s):  
Phase I ◽  
Dose Escalation ◽  
Dose Escalation Study ◽  
Advanced Malignancies

scholarly journals Phase I, multicenter, dose‐escalation study of avadomide in adult Japanese patients with advanced malignancies

2020 ◽  
Vol 112 (1) ◽  
pp. 331-338
Author(s):  
Kiyohiko Hatake ◽  
Takaaki Chou ◽  
Toshihiko Doi ◽  
Yasuhito Terui ◽  
Harumi Kato ◽  
...  
Keyword(s):  
Phase I ◽  
Dose Escalation ◽  
Japanese Patients ◽  
Dose Escalation Study ◽  
Advanced Malignancies

Abstract C221: EZN‐2208, a novel anticancer agent, in patients (pts) with advanced malignancies: A phase 1 dose‐escalation study

2009 ◽  
Author(s):  
Amita Patnaik ◽  
Kyriakos P. Papadopoulos ◽  
Muralidhar Beeram ◽  
Debbie Kee ◽  
Anthony W. Tolcher ◽  
...  
Keyword(s):  
Dose Escalation ◽  
Anticancer Agent ◽  
Phase 1 ◽  
Dose Escalation Study ◽  
Advanced Malignancies

Abstract B51: A phase I dose‐escalation study of MGCD265 in patients with advanced malignancies (study 265‐102)

2009 ◽  
Author(s):  
Patricia LoRusso ◽  
Razelle Kurzrock ◽  
Amy Weise ◽  
Elisabeth Heath ◽  
Michel Drouin ◽  
...  
Keyword(s):  
Phase I ◽  
Dose Escalation ◽  
Dose Escalation Study ◽  
Advanced Malignancies
Sign in / Sign up

Export Citation Format

Share Document